Top Markets
Coin of the day
Agile Therapeutics, Inc. Agile Therapeutics, Inc.

Agile Therapeutics, Inc.

AGRX
Rankning i aktier #38231
Agile Therapeutics, Inc. operates as a women's healthcare enterprise dedicated... Agile Therapeutics, Inc. operates as a women's healthcare enterprise dedicated to the research, development, and market introduction of prescription contraception in the United States. Its flagship product is Twirla (also known by its development code, AG200-15), a combined hormonal contraceptive delivered through a patch applied once weekly. The company is also progressing with several pipeline innovations, including variations of Twirla and other new products: AG200-15 Extended Regimen (ER): A regimen designed to limit a woman to four withdrawal bleeding occurrences annually. AG200-15 smaller patch (SmP): This iteration aims for shorter, lighter withdrawal bleeds and potentially enhanced contraceptive efficacy. AG200-15 ER SmP: A combined regimen that allows for an extended contraceptive cycle while simultaneously providing fewer, lighter annual bleeding episodes. P-Patch: A contraceptive patch containing only progestin, specifically intended for women who cannot or choose not to use estrogen. Agile Therapeutics, Inc. was founded in 1997 and is based in Princeton, New Jersey.
Aktiekurs
$1.51
Senast synkroniserad: 2024-08-26
Marknadsvärde
$1.12M
Förändring (1 dag)
0.00%
Förändring (1 år)
0.00%
Land
US
Handel Agile Therapeutics, Inc. (AGRX)

Kategori

Vinst för Agile Therapeutics, Inc. (AGRX)
Vinst i Jun 2024 TTM: $-15.86M
Enligt de senaste finansiella rapporterna från Agile Therapeutics, Inc. är företagets nuvarande vinst $-15.86M. År 2022 hade företaget en vinst på $-30.09M, en ökning jämfört med vinsten år 2021 som var $-74.89M. Vinsten som visas på denna sida är vinsten före räntor och skatt, även kallad EBIT.
Vinshistorik för Agile Therapeutics, Inc. från 2012 till 2026
Vinst vid slutet av varje år
År Vinst Ändra
2026 (TTM) $-15.86M 9.62%
2023 $-14.47M -51.92%
2022 $-30.09M -59.83%
2021 $-74.89M 44.44%
2020 $-51.85M 178.69%
2019 $-18.61M -8.15%
2018 $-20.26M -28.43%
2017 $-28.30M -11.04%
2016 $-31.82M -12.37%
2015 $-36.31M 84.02%
2014 $-19.73M 37.77%
2013 $-14.32M -38.43%
2012 $-23.26M 0.00%
Vinst för liknande företag eller konkurrenter